Legal Finance Updated: May 23, 2026 Reading time: 20 min

Underwriting Pre-Settlement Risk: Modeling Plaintiff Net Recovery

45% Max contingency fee at trial stage in many jurisdictions
10-15% Conservative LTV cap on plaintiff net recovery for pre-settlement advances
$0 What a funder recovers on a non-recourse advance if the case is lost
30%+ Typical gross settlement consumed by liens and costs before plaintiff payout

Why Gross Settlement Estimates Destroy Litigation Funder Capital

The number on the demand letter is not the number that matters. A $500,000 settlement estimate sounds like a safe base for a $50,000 non-recourse advance. After a 40% contingency fee, $75,000 in expert witness costs, a $120,000 medical lien from the health insurer, and a $15,000 Medicare subrogation claim, the plaintiff’s share is $116,000. The advance repayment with charges might be $72,000. That leaves $44,000 to the plaintiff after a case that took three years.

That math is not unusual. It is standard for serious personal injury cases with significant medical treatment. What is unusual is a litigation funder who modeled it correctly before writing the check.

Most pre-settlement funding decisions are made using one of two inputs: the gross settlement estimate from the plaintiff attorney, or a competitor’s advance amount as a proxy for case value. Both inputs are wrong for underwriting purposes. The only input that matters is the projected net-recovery floor, which requires building the disbursement sheet before the case settles.

The non-recourse structure amplifies this problem. If the case resolves for less than projected, or the plaintiff receives nothing at trial, the funder loses the entire advance. There is no recourse against the plaintiff personally. The disbursement math is not a formality. It is the only financial protection the funder has.

The litigation funding industry processed over $3.2 billion in consumer advances in 2024, according to data tracked by the American Legal Finance Association (ALFA). The firms that generate consistent returns are the ones that have built systematic net-recovery models. The ones that do not are the ones losing capital on cases where the gross settlement was real but the net payout to the plaintiff was negligible.

🏛
Government Authority Source The Centers for Medicare and Medicaid Services (CMS) publishes mandatory reporting requirements and lien resolution procedures for personal injury settlements involving Medicare beneficiaries. Funders and attorneys must understand these rules before disbursement: CMS Medicare Secondary Payer & Lien Recovery Reference Guide.

The Settlement Disbursement Hierarchy: Who Gets Paid First

Settlement proceeds do not flow to the plaintiff in a lump sum. They flow through a structured disbursement sequence governed by the retainer agreement, state bar ethics rules, and federal law (for Medicare and Medicaid liens). Understanding this sequence is the foundational skill of pre-settlement underwriting.

1

Gross Settlement Check Received into Attorney Trust Account

The full settlement amount is deposited into the attorney’s IOLTA (Interest on Lawyers Trust Account). No funds leave the trust until all disbursements are calculated and approved.

2

Attorney Contingency Fee Disbursed (Off the Gross)

The fee agreement almost always applies the percentage to the gross settlement, not the net. A 40% fee on a $500,000 gross settlement is $200,000, regardless of what liens are outstanding. This is the first and largest deduction.

3

Case Costs and Expert Disbursements Reimbursed (From Plaintiff Share)

Advanced costs are repaid from the plaintiff’s remaining share ($300,000 after fees). Expert witnesses, deposition transcripts, court filing fees, investigation costs, and medical record retrieval all come out here. This can range from $10,000 on a simple case to $200,000+ on complex medical malpractice.

4

Medical Liens and Subrogation Claims Satisfied (From Plaintiff Share)

Medicare, Medicaid, ERISA health plans, workers’ compensation carriers, and hospital lien holders all have priority claims. Federal liens (Medicare, Medicaid) carry statutory priority that cannot be waived without government consent. These are paid from the plaintiff share after costs.

5

Pre-Settlement Advance Repayment (From Plaintiff Share)

The litigation funder is paid here. The advance principal plus all accumulated funding charges is deducted from what remains after costs and liens. The funder’s contractual repayment cap (if any) applies at this stage.

6

Net Recovery Distributed to Plaintiff

Whatever remains after all prior disbursements is the plaintiff’s take-home. This is the number that determines whether the plaintiff considers the outcome fair and whether the funder’s advance was adequately secured.

The critical insight for funders: steps 2 through 5 all come before the plaintiff receives anything. And steps 3 through 5 all draw from the same pool, the plaintiff’s share after attorney fees. A large contingency fee compresses that pool before a single lien is paid.

State bar rules vary on fee calculation. Some jurisdictions require contingency fees to be calculated on the net recovery (after costs), not the gross. California, for example, requires the retainer agreement to clearly specify whether fees are calculated on gross or net. Always review the specific fee agreement before modeling disbursements.

Sliding-Scale Contingency Fee Math: Why Stage Matters More Than Percentage

A flat 33% contingency fee is a simplified assumption. Most PI retainer agreements use a sliding scale that increases the attorney’s percentage as the case progresses through litigation stages. The logic: a case that settles in 30 days required minimal attorney effort. A case that goes to verdict after a three-week trial consumed years of attorney time and firm capital. The fee structure compensates for that additional risk and effort.

The Standard Three-Tier Structure

Common Sliding-Scale Contingency Fee Tiers
Case Stage at Resolution Typical Fee Range Impact on $500K Gross Plaintiff Share Remaining
Pre-suit settlement (resolved before complaint filed) 25% to 33.3% $125,000 to $167,000 $333,000 to $375,000
Post-filing, pre-trial settlement 33.3% to 40% $167,000 to $200,000 $300,000 to $333,000
After trial begins or during appeal 40% to 45% $200,000 to $225,000 $275,000 to $300,000
Medical malpractice (statutory caps) Varies by state; CA caps at 25% on first $500K after MICRA reform $125,000 (CA cap example) $375,000

Fee percentages are common ranges, not legal standards. Actual fees depend on the specific retainer agreement. Some states impose statutory caps on contingency fees, particularly in medical malpractice cases. Always verify the executed retainer agreement before modeling disbursements.

The Stage Risk Problem for Funders

When a litigation funder approves an advance, the case is at a specific stage. But the funder does not control how long the case runs. A case funded during mediation that unexpectedly proceeds to trial generates a higher attorney fee than the funder modeled. That increased fee comes out of the plaintiff’s share, directly reducing the amount available to repay the advance.

Conservative funders model the net recovery at the highest applicable fee tier, not the current stage. If a case is currently in mediation at a 33% fee stage, they model the disbursement assuming it goes to trial at 40% or 45%. The resulting net-recovery floor is lower, but it protects against the most expensive outcome.

Conservative Net Recovery Floor Formula (Stress Test):
Net Recovery Floor = Gross Settlement Estimate
    − (Gross Settlement × Maximum Fee Tier %)
    − Expert and Disbursement Budget (High-End Estimate)
    − Total Lien Amount (Verified + Estimated Unverified)
    − Advance Repayment (Principal + Maximum Charges)
= Minimum Amount Available to Plaintiff After All Deductions

If that floor is negative or uncomfortably thin, the advance is underpriced relative to its risk. The math does not care about case theory or liability estimates. It is arithmetic on the disbursement sequence.

Medical Liens and Subrogation: The Variable That Breaks Most Models

Attorney fees are predictable. Expert costs can be estimated. Medical liens are the wildcard that breaks pre-settlement advance models more than any other variable. They are often unknown at the time of funding, they grow as treatment continues, and certain federal liens carry statutory priority that even the plaintiff’s attorney cannot negotiate away without government consent.

The Four Categories of Medical Liens

Federal Priority Liens (Non-Negotiable)

  • Medicare (CMS): Federal statutory right to recover from any settlement. Conditional payments accumulate from date of injury. Must be resolved before disbursement or the attorney faces personal liability.
  • Medicaid (State agency): Similar to Medicare but administered by state agencies. Reduction rights vary by state after the Arkansas v. Ahlborn decision.
  • TRICARE / VA: Military health coverage carries federal recovery rights similar to Medicare.

Non-Federal Liens (Negotiable)

  • ERISA health plans: Self-funded employer health plans under ERISA often have full subrogation rights that override state anti-subrogation laws. The plan terms control.
  • Hospital liens: Many states allow hospitals to file statutory liens on personal injury settlements for unpaid treatment. Lien amounts are often reduced in negotiation.
  • Private health insurers: Subject to state law; subrogation rights vary significantly. Some states have anti-subrogation laws that limit or eliminate insurer recovery rights.
  • Workers’ comp carriers: Have statutory subrogation rights against third-party tort recoveries in most states.

Why Funders Cannot Ignore Unknown Liens

At the time of funding, the full lien picture is often incomplete. Treatment may still be ongoing. Medicare conditional payment letters have not arrived. The plaintiff may not have disclosed a prior health insurer. Every unknown lien that surfaces during the disbursement process reduces the net recovery available to repay the funder’s advance.

The CMS 60-day rule creates a specific deadline risk. Medicare requires notification of any pending personal injury lawsuit or settlement within 60 days. When settlement is reached, CMS must receive notice and provide a final demand letter before disbursement. If the attorney distributes funds before resolving the Medicare lien, both the attorney and the funder (as a party with a financial interest in the settlement) may face liability under the Medicare Secondary Payer Act.

For underwriting purposes, the standard practice among conservative funders is to request a Medicare conditional payment letter, an ERISA plan document (if applicable), and a lien registry search before approving any advance. Where those documents are unavailable, the funder applies a lien reserve to the net recovery calculation based on the total treatment costs reported in the medical records.

🏛
CMS Medicare Secondary Payer Compliance The Medicare Secondary Payer (MSP) Act governs lien recovery rights on personal injury settlements. The official CMS resource for attorneys and insurers managing conditional payment resolution: CMS Medicare Secondary Payer (MSP) Official Resource Center.

LTV Methodology for Non-Recourse Advances: How Top Funders Set the Cap

LTV in litigation finance is defined as the advance amount divided by the projected plaintiff net recovery. It is not the advance divided by the gross settlement. Funders who calculate LTV against the gross are systematically underestimating their exposure and will eventually fund a case where the net recovery does not cover the advance repayment.

LTV Thresholds Used by Conservative Litigation Funders

Advance ≤10% of projected net recovery floor Conservative / Safe
Advance 10–15% of projected net recovery floor Standard Practice
Advance 15–20% of projected net recovery floor Elevated Risk / Requires Approval
Advance 20–25% of projected net recovery floor High Risk / Senior Underwriter Sign-Off
Advance >25% of projected net recovery floor Outside Policy / Requires Exception
Advance amount exceeds conservative net recovery floor Decline / Capital at Full Risk

The 10-15% standard is not arbitrary. It reflects two sources of model risk: lien uncertainty and settlement compression. Even well-modeled cases can settle for 20-30% less than the demand, particularly in jurisdictions with conservative jury pools or in cases where liability is contested. A 15% LTV against the projected net recovery provides a buffer against both a lower-than-expected settlement and a higher-than-expected lien resolution.

Calculating the Net Recovery Floor for LTV Purposes

LTV Calculation (Conservative Method):
Step 1: Gross Settlement = Use the plaintiff attorney’s conservative estimate (not best case)
Step 2: Attorney Fee = Gross × Maximum Fee Tier % (assume trial stage for conservative model)
Step 3: Plaintiff Share = Gross Settlement − Attorney Fee
Step 4: Adjusted for Costs = Plaintiff Share − Verified Expert and Disbursement Budget
Step 5: Lien-Adjusted Net = Adjusted for Costs − (Verified Liens + Estimated Unverified Liens)
Step 6: Net Recovery Floor = Lien-Adjusted Net (before advance repayment)
Step 7: Maximum Advance = Net Recovery Floor × LTV Cap (e.g., 15%)

LTV = Proposed Advance ÷ Net Recovery Floor

Expert Witness and Disbursement Budgeting: The Numbers by Case Type

Expert and disbursement costs are advanced by the law firm during litigation and reimbursed from the plaintiff’s share at settlement. For a litigation funder, these costs reduce the net recovery pool that their advance depends on. Underestimating them is a common model error.

Typical Expert and Disbursement Costs by Case Type
Case Type Low End High End Primary Cost Drivers
Auto Accident (soft tissue) $3,000 $15,000 Accident reconstruction, treating physician deposition, medical records
Auto Accident (catastrophic injury) $25,000 $100,000 Life care planner, economist (lost wages), neurology expert, accident reconstruction, biomechanical expert
Medical Malpractice $50,000 $300,000+ Multiple specialty experts, standard of care reviews, hospital records, nurse life care planner
Products Liability (single plaintiff) $40,000 $200,000 Engineering experts, toxicologists, corporate document review, deposition costs
Mass Tort (per plaintiff allocation) $500 $5,000 Shared expert costs allocated across the plaintiff pool; individual deposition costs
Workers’ Compensation / Third-Party $5,000 $30,000 Vocational rehabilitation expert, accident reconstruction, independent medical exam
Pro Tip for Underwriters: Request a current case cost ledger from the plaintiff attorney before approving any advance over $25,000. The ledger shows costs already advanced and outstanding invoices. Adding those to the firm’s projected future costs gives you a verified disbursement number rather than a guess. Firms that refuse to provide a cost ledger are a flag, not a friction point.

Mass Tort Portfolio Underwriting: Different Rules, Same Math

Mass tort funding operates on different economics than single-plaintiff advances. A litigation funder providing a portfolio advance to a plaintiff attorney with 200 opioid cases or 150 hernia mesh cases is not modeling one disbursement sheet. They are underwriting a statistical distribution of outcomes across the entire portfolio.

How Portfolio LTV Works

In a mass tort portfolio, individual case values are highly variable. Some plaintiffs have strong injury profiles and significant damages. Others have weaker cases that may settle for nuisance value or be dismissed outright. The funder underwrites the portfolio based on weighted average net recovery projections across the case mix, not the individual best cases.

The standard approach is to categorize cases into tiers (Tier 1: strong liability and significant damages, Tier 2: standard liability and moderate damages, Tier 3: marginal cases or challenged liability) and assign probability-weighted settlement estimates to each tier. The portfolio net recovery is the sum of weighted net recoveries across all tiers, minus attorney fees, shared expert costs, and per-plaintiff lien estimates.

The Common Fee Structure in Mass Tort Advances

Mass tort contingency fees are often set by court order in MDL proceedings rather than individual retainer agreements. The court establishes a common benefit fund assessment (typically 6% to 8% of each individual plaintiff’s settlement) that is deducted before the retained attorney’s fee is calculated. This adds another layer of cost that single-plaintiff models do not capture.

MDL common benefit deductions are off the gross. In large MDLs, the judge typically orders that a percentage (e.g., 7%) be withheld from every settlement to fund the common benefit work done by lead counsel. That deduction comes before the individual plaintiff attorney calculates their own contingency fee on the remaining amount. For portfolio funders, this means the effective fee rate is higher than the retainer agreement states.

Full Worked Example: PI Auto Accident Case Disbursement Sheet

Here is a complete net recovery calculation for a realistic personal injury auto accident case at the pre-settlement funding stage. This is the analysis a litigation funder should complete before approving any advance.

Case Profile

Auto Accident, Serious Orthopedic Injury — Pre-Trial Stage

Plaintiff Attorney’s Settlement Estimate (Conservative)$450,000
Case StagePost-Filing, Pre-Trial
Contingency Fee (Retainer Agreement)40% (post-filing rate)
Expert Costs to Date (Verified from Cost Ledger)$38,000
Projected Additional Expert Costs to Resolution$22,000
Medicare Conditional Payment (CMS Letter Received)$62,000
Private Health Insurer Lien (ERISA Plan, Full Subrogation)$28,000
Advance Requested by Plaintiff$35,000

Step-by-Step Disbursement Calculation

Conservative Disbursement Model

Projected Settlement Disbursement Sheet

Gross Settlement$450,000
DEDUCTION 1: Attorney Contingency Fee (40% of Gross)($180,000)
Plaintiff Share After Attorney Fee$270,000
DEDUCTION 2: Case Costs and Expert Disbursements($60,000)
($38,000 incurred + $22,000 projected)
Plaintiff Share After Costs$210,000
DEDUCTION 3: Medicare Conditional Payment Lien($62,000)
DEDUCTION 4: ERISA Health Plan Subrogation Lien($28,000)
Plaintiff Share After All Liens$120,000
DEDUCTION 5: Advance Repayment (Principal $35K + Charges ~$15K)($50,000)
PLAINTIFF NET RECOVERY$70,000
Plaintiff receives $70,000 from a $450,000 gross settlement (15.6% of gross). The funder’s $35,000 advance represents 29.2% LTV against the $120,000 post-lien plaintiff share, which is above the 15% conservative threshold. This advance is at elevated risk if the case settles lower than projected or additional liens surface.

The LTV Reality Check

LTV Against Gross (Incorrect Method):
$35,000 advance ÷ $450,000 gross = 7.8% LTV → Looks safe

LTV Against Net Recovery Floor (Correct Method):
$35,000 advance ÷ $120,000 post-lien plaintiff share = 29.2% LTV → Above policy

Maximum Advance at 15% LTV Policy:
$120,000 × 15% = $18,000 maximum advance under policy

The difference between 7.8% and 29.2% LTV is the difference between a safe advance and a capital-at-risk position. The funder who approved this advance based on gross settlement LTV has $35,000 outstanding against a plaintiff share that, after lien negotiations, might be as low as $80,000 in a downside scenario.

The funder who models net recovery correctly either declines the advance or caps it at $18,000 per policy.

Pre-Advance Underwriting Checklist for Litigation Finance Teams

Every advance decision should clear these items before approval. The checklist is organized by the stage of analysis: case documentation, disbursement modeling, and LTV validation.

Case Documentation (Gather Before Modeling)

  1. Executed retainer agreement confirming contingency fee percentage at each stage and whether fees are calculated on gross or net
  2. Current case cost ledger showing all disbursements advanced and outstanding invoices from vendors
  3. Medical records index with total treatment costs to date and anticipated future treatment
  4. Medicare conditional payment letter from CMS (if plaintiff is Medicare-eligible)
  5. Medicaid confirmation from state agency (if plaintiff is or was Medicaid-enrolled during treatment period)
  6. ERISA plan document or subrogation demand letter from employer health plan
  7. Hospital lien filings from any treating facilities in states with hospital lien statutes
  8. Workers’ compensation carrier subrogation demand (if work-related injury)
  9. Liability assessment memo from the plaintiff attorney summarizing the basis for the settlement estimate

Disbursement Modeling (Build Before Approving)

  1. Model gross settlement using attorney’s conservative estimate, not best case
  2. Apply maximum fee tier percentage (trial stage), not current stage percentage
  3. Use verified cost ledger plus high-end future cost projection
  4. Apply all verified liens at face value; do not assume negotiated reductions until negotiations are complete
  5. Include a 15% lien reserve for unverified or unknown liens not yet surfaced in records
  6. Calculate advance repayment at maximum charge rate over projected case duration
  7. Compute net recovery floor and LTV against that floor

LTV Validation (Final Gate Before Approval)

  1. Confirm proposed advance does not exceed LTV policy cap against net recovery floor
  2. Run a downside scenario: what is the LTV if the case settles at 70% of the conservative estimate?
  3. Confirm no prior advance exists on this case from another funder
  4. Verify plaintiff attorney has not assigned any portion of future fees to a third party
  5. Confirm advance contract contains cap provision limiting total repayment to a specific maximum multiple (e.g., 3x principal)
Pro Tip: The downside scenario at 70% of the conservative estimate is your real underwriting floor. A conservative estimate that is already discounted 20% from demand means your 70% stress scenario is a 44% reduction from the original demand letter number. If the LTV at that scenario exceeds 25%, the advance is mispriced regardless of how strong liability looks.

FAQs for Litigation Finance Professionals

How is a plaintiff net recovery calculated after contingency fees and medical liens?

Start with the gross settlement. Subtract the attorney contingency fee calculated on the gross (typically 33% to 45% depending on case stage). The remainder is the plaintiff share. From the plaintiff share, subtract case costs and expert disbursements, all verified medical liens and subrogation claims, and the pre-settlement advance repayment. Whatever remains is the plaintiff’s net recovery. The key insight is that costs and liens both come from the plaintiff’s share after attorney fees, so the attorney’s percentage off the gross acts as a first and immediate compression on what is available for all other obligations.

Can a litigation funder negotiate medical liens directly?

Funders typically do not negotiate liens directly. Lien resolution is the plaintiff attorney’s responsibility, and the attorney has both the professional standing and the tactical leverage to negotiate reductions. However, sophisticated funders often require lien negotiation as a precondition to disbursement, or at minimum require that lien negotiation be initiated before the advance is approved. Where a lien is unresolved at the time of funding, the conservative underwriting approach is to model it at face value and treat any negotiated reduction as upside, not as an expected assumption.

What happens to a pre-settlement advance if the plaintiff loses at trial?

Nothing. A properly structured non-recourse advance is not repayable if the plaintiff receives no recovery. The funder absorbs the entire loss. This is why LTV against net recovery floor (not gross settlement) is the correct underwriting metric. The funder is essentially buying a small percentage interest in the plaintiff’s expected net recovery. If that recovery does not materialize, the entire advance is written off. This non-recourse structure is what distinguishes litigation funding from a loan and is why LTV discipline is non-negotiable for portfolio sustainability.

How do ERISA health plan liens differ from standard insurance subrogation?

ERISA self-funded plans have substantially stronger recovery rights than state-regulated health insurance policies. Because ERISA is a federal law that preempts state insurance regulations, state anti-subrogation laws do not apply to ERISA plans. A self-funded employer health plan can exercise full subrogation rights regardless of what state the plaintiff lives in, and the plan terms often include make-whole doctrine waivers that allow recovery even when the plaintiff is not fully compensated. For underwriting purposes, an ERISA plan lien should be modeled at face value until a negotiated reduction is confirmed in writing by the plan administrator.

What is the standard repayment multiple cap in consumer litigation funding?

Standard practice in the consumer pre-settlement funding market is to cap total repayment at a stated multiple of the original advance, typically between 2x and 3x depending on the funder and the state. Some states have enacted litigation funding disclosure and rate laws that impose maximum charge caps. Arkansas, Indiana, Tennessee, and Ohio have enacted various forms of litigation funding regulation that affect how charges can accrue. Funders operating in regulated states must confirm their repayment structure complies with applicable state law before contracting with plaintiffs who reside in those jurisdictions.

How does the ALFA regulate pre-settlement funding companies?

The American Legal Finance Association (ALFA) is the primary industry trade association for consumer legal funding companies. ALFA is a self-regulatory organization that establishes best practice standards for disclosure, rate transparency, and non-interference in attorney-client relationships. Membership in ALFA and adherence to its best practices is voluntary, not statutory, unless a specific state has adopted statutory regulation. For a current list of ALFA member companies and their best practice standards, visit americanlegalfinance.org.